Corcept Therapeutics | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.23B 93.19M 2025-06
Alaunos Therapeutics USD 2.76M 795K 2024-12
ANI Pharmaceuticals USD 1.34B 50.57M 2025-06
Ardelyx USD 435.75M 67.89M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
J&J USD 193.67B 13.57B 2025-03
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Merck USD 117.52B 2.4B 2025-06
Novartis USD 104.4B 4.45B 2025-06
Novartis USD 102.25B 1.28B 2024-12
Pacira USD 1.54B 49.41M 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
TG Therapeutics USD 702.61M 45.92M 2025-06


Corcept Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.